Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 374.05
-6.95 (-1.82%)
At close: Sep 16, 2026
Biocon Market Cap
Biocon has a market cap or net worth of 618.65 billion as of September 16, 2026. Its market cap has increased by 29.41% in one year.
Market Cap
618.65B
Enterprise Value
760.06B
Revenue
173.21B
Ranking
n/a
PE Ratio
124.90
Stock Price
374.05
ChartMarket Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 618.65B, an increase of 1,262.28%. That is a compound annual growth rate of 12.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 618.65B | 17.69% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aarti Drugs | 39.10B |
| Hester Biosciences | 19.48B |
| Titan Biotech | 18.06B |
| Zenotech Laboratories | 2.75B |
| CCME Global | 1.36B |
| Bharat Immunologicals & Biologicals Corporation | 652.45M |
| Transgene Biotek | 209.88M |
| Hindustan Bio Sciences | 82.42M |